Xiuqin Jia | Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Xiuqin Jia | Neuroscience | Best Researcher Award

Beijing Chaoyang Hospital | China

Dr. Xiuqin Jia, Ph.D., Associate Professor in the Department of Radiology at Beijing Chaoyang Hospital, Capital Medical University, is a distinguished researcher whose work has significantly advanced the fields of neuroimaging and cognitive neuroscience. Her research addresses the neural correlates of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and mild cognitive impairment, as well as cerebrovascular disorders including CADASIL and cerebral small vessel disease. Through computational modeling and multimodal neuroimaging approaches, she has provided innovative insights into disease mechanisms, progression, and early diagnostic markers, with direct implications for clinical practice and therapeutic intervention. According to Scopus, Dr. Xiuqin Jia has authored 75 publications, which have collectively received 1,716 citations across 1,492 documents, establishing a robust h-index of 23 that reflects her sustained impact and scholarly influence. She has successfully secured major funding as Principal Investigator for projects under the National Natural Science Foundation of China, the Beijing Municipal Natural Science Foundation, and other national programs, underscoring her leadership in cutting-edge research. In addition to her academic contributions, Dr. Xiuqin Jia serves as a Review Editor for Frontiers in Aging Neuroscience and holds important positions in multiple professional societies, promoting interdisciplinary collaboration between radiology, brain science, and artificial intelligence. Her achievements have been recognized through prestigious honors, including the Beijing Outstanding Doctoral Graduate Award, the Capital Medical University Scientific and Technological Progress Award, and the Chinese Medical Science and Technology Youth Award. With her remarkable record of innovation, leadership, and international recognition, Dr. Jia is an outstanding candidate for the Best Researcher Award.

Profile: Scopus | Google Scholar | ORCID

Featured Publications

Huang, Z., Liang, P., Jia, X., Zhan, S., Li, N., Ding, Y., Lu, J., Wang, Y., & Li, K. (2012). Abnormal amygdala connectivity in patients with primary insomnia: Evidence from resting state fMRI. European Journal of Radiology, 81(6), 1288–1295.

Liang, P., Wang, Z., Yang, Y., Jia, X., & Li, K. (2011). Functional disconnection and compensation in mild cognitive impairment: Evidence from DLPFC connectivity using resting-state fMRI. PLoS ONE, 6(7), e22153.

Wang, Z., Jia, X., Liang, P., Qi, Z., Yang, Y., Zhou, W., & Li, K. (2012). Changes in thalamus connectivity in mild cognitive impairment: Evidence from resting state fMRI. European Journal of Radiology, 81(2), 277–285.

Duan, Y., Liu, Y., Liang, P., Jia, X., Yu, C., Qin, W., Sun, H., Liao, Z., Ye, J., & Li, K. (2012). Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study. European Journal of Radiology, 81(2), e110–e114.

Wang, Z., Liang, P., Jia, X., Jin, G., Song, H., Han, Y., Lu, J., & Li, K. (2012). The baseline and longitudinal changes of PCC connectivity in mild cognitive impairment: A combined structure and resting-state fMRI study. PLoS ONE, 7(5), e36838.

Wang, Z., Liang, P., Jia, X., Qi, Z., Yu, L., Yang, Y., Zhou, W., Lu, J., & Li, K. (2011). Baseline and longitudinal patterns of hippocampal connectivity in mild cognitive impairment: Evidence from resting state fMRI. Journal of the Neurological Sciences, 309(1–2), 79–85.

Jia, X., Liang, P., Li, Y., Shi, L., Wang, D., & Li, K. (2015). Longitudinal study of gray matter changes in Parkinson disease. American Journal of Neuroradiology, 36(12), 2219–2226.

Liu, Y., Liang, P., Duan, Y., Jia, X., Wang, F., Yu, C., Qin, W., Dong, H., Ye, J., & Li, K. (2011). Abnormal baseline brain activity in patients with neuromyelitis optica: A resting-state fMRI study. European Journal of Radiology, 80(2), 407–411.

Qingbao Guo | Neuroscience | Outstanding Scientist Award

Prof. Qingbao Guo | Neuroscience | Outstanding Scientist Award

Xi’an No.9 Hospital | China

Prof. Qingbao Guo is a highly accomplished Associate Chief Physician in the Department of Neurosurgery at the Second Affiliated Hospital of the Air Force Medical University (formerly Tangdu Hospital), China. He specializes in cerebrovascular disorders, brain tumors, and functional neurosurgery, and is recognized for his excellence in the diagnosis and treatment of moyamoya disease and other complex neurological conditions.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. Extensive Clinical Experience:

    • Over 20 years of progressive clinical practice in neurosurgery, including leadership as Associate Chief Physician at a top-tier military hospital.

    • Strong surgical expertise in cerebrovascular diseases, brain tumors, and functional neurosurgery, which are critical areas in modern neurosurgical practice.

  2. Academic Qualifications & Research:

    • A recent Ph.D. in Neurosurgery (2021–2024) focused on moyamoya disease (MMD)—a rare but significant cerebrovascular disorder.

    • Earlier Master’s-level research on peripheral vascular diseases, showing continuity in vascular-focused research.

    • Mentorship under established experts (Professors Lian Duan and Yanzheng He), enhancing academic rigor.

  3. Contribution to National Defense Health System:

    • His long-term service in military medical institutions (Air Force Medical University) underscores contributions to military medicine, a high-impact field with national importance.

  4. Interdisciplinary Relevance:

    • His work bridges clinical practice and surgical innovation, especially in the surgical management of complex neurological diseases, offering translational value to both academic and applied medicine.

🎓 Education

Prof. Qingbao Guo began his academic journey with a Bachelor’s degree in Clinical Medicine from Yan’an University (1999–2004). He furthered his specialization with a Master’s degree in Surgery (2008–2011) from Southwest Medical University, under the supervision of Prof. Yanzheng He, where he focused on clinical approaches to peripheral vascular diseases. Most recently, he earned his Ph.D. in Neurosurgery (2021–2024) from the Chinese PLA Medical School, mentored by Prof. Lian Duan, with research concentrating on the pathogenesis and surgical management of moyamoya disease.

💼 Professional Experience

Prof. Qingbao Guo has an extensive and progressive professional background in neurosurgery. He is currently serving as an Associate Chief Physician at Tangdu Hospital since September 2012, where he has amassed advanced surgical experience in managing brain tumors, vascular pathologies, and functional neurosurgical disorders. Prior to this, he was an Attending Physician at the First Affiliated Hospital of Southwest Medical University (July 2011 – August 2012), where he handled numerous vascular cases. His medical career began as a Resident Physician at Shaanxi Sengong Hospital (July 2004 – August 2008).

🔬 Research Interests On Neuroscience

Prof. Qingbao Guo’s research focuses on the pathophysiology and surgical treatment of cerebrovascular diseases, particularly moyamoya disease, a rare but serious condition affecting intracranial arteries. He is also interested in neuro-oncology, vascular neurosurgery, and advancements in functional neurosurgical procedures, with a vision to bridge translational neuroscience and surgical innovation.

🏆 Awards & Nominations

Prof. Qingbao Guo has been acknowledged for his clinical excellence and academic contribution through multiple hospital-level and regional honors. He is a nominee for the [Insert Award Name Here, e.g., “Outstanding Neurosurgeon Researcher Award 2025”] in recognition of his pioneering work in moyamoya disease surgical treatment and his consistent commitment to patient-centered research and education.

📚 Publications

🔬 Genetic Associations and Polymorphisms
  1. MTHFR Polymorphism and EDAS-induced Collateral Formation

    • [DOI: 10.3171/2024.1.JNS232121]
      Highlights the genetic influence (MTHFR) on surgical angiogenesis success post-EDAS in MMD patients.

  2. RNF213 p.R4810K Variant and Unfavorable Outcomes in Pediatric EDAS

    • [DOI: 10.1155/2024/1844190]
      Strong linkage of the RNF213 mutation with poor long-term outcomes, particularly relevant in East Asian populations.

🧪 Biomarker and Multi-Omics Studies
  1. Proteomic & Metabolomic Profiles in Pediatric MMD

    • [DOI: 10.2147/JIR.S471538]
      Identifies core disrupted pathways, potentially pointing toward new diagnostic or therapeutic targets.

  2. Complement C3 Expression & Postoperative Vasculopathy

    • [DOI: 10.2147/JIR.S451538]
      Suggests inflammatory markers like C3 as predictors of vascular changes post-intervention.

🧠 Neuroimaging and Risk Stratification
  1. MRI Vessel Wall Enhancement and MMD Outcomes

    • [DOI: 10.1007/S00330-023-10535-0]
      High-resolution MRI features were linked to clinical risk, potentially informing preoperative planning.

  2. Nomograms for Predicting Rebleeding and Outcomes

    • [DOI: 10.3171/2024.2.JNS232744]
      Well-validated clinical tools that integrate genetics and clinical features for long-term prognosis.

🧬 Pathophysiology and Comorbid Disease Connections
  1. Transcriptomics in MMD and SLE Crosstalk

    • [DOI: 10.3389/FIMMU.2024.1456392]
      A novel systems biology approach to uncover common pathways between MMD and autoimmune diseases like SLE.

  2. ZEB2 and Brain Microvascular Dysfunction Post-ICH

    • [DOI: 10.1080/15384101.2021.1959702]
      Delves into molecular mechanisms of endothelial dysfunction, bridging stroke and hemorrhage pathology.

📉 Risk Factors in Pediatric and Elderly Cohorts
  1. Preoperative Infarction & Pediatric Risk Factors

    • [DOI: 10.1007/S12975-023-01167-Z]
      Targeted focus on predictive markers in vulnerable pediatric populations.

  2. Outcomes in Elderly Post-Conservative vs. EDAS Treatment

  • [DOI: 10.3171/2023.7.JNS231060]
    Offers insights into age-specific management strategies and long-term care plans.

🔚 Conclusion

Prof. Qingbao Guo stands out as a dedicated neurosurgeon, educator, and researcher, committed to transforming patient outcomes through clinical expertise and scientific inquiry. His extensive training, hands-on experience, and impactful research make him a compelling candidate for any award celebrating excellence in medical and surgical innovation.

Chengqun Wei | Neuroscience | Best Researcher Award

Mr. Chengqun Wei | Neuroscience | Best Researcher Award

Associate Chief Physician | Huaian Hospital of Huaian city (Huaian Cancer Hospital) | China

Dr. Chengqun Wei is the Director of the Neurology Department and an Associate Senior Physician at Huaian Hospital of Huaian City. With a medical doctorate and a specialization in neurology, he has accumulated extensive expertise in geriatric neurology. Since beginning his medical career in 2012, Dr. Wei has dedicated over seven years to the treatment of acute cerebrovascular diseases, neurological infections, and demyelinating disorders. His vast clinical experience also includes managing elderly patients with comorbidities such as hypertension, diabetes, and cardiovascular diseases.

Profile👤

Scopus

Strengths for the Awards✨

Extensive Medical Expertise: With a Ph.D. in Neurology and over a decade of clinical experience, Dr. Wei has demonstrated profound knowledge in geriatric neurology, cerebrovascular diseases, and neurological infections. His ability to manage complex neurological conditions in elderly patients is highly commendable.

Research Contributions: Dr. Wei has authored 7 SCI-indexed publications, indicating a strong research output. Additionally, his involvement in multiple provincial-level research projects as a principal investigator or key participant highlights his active role in advancing medical knowledge.

Technical Proficiency: His expertise in network pharmacology, bioinformatics analysis, and web data mining showcases his ability to integrate computational tools with medical research, a valuable asset in modern biomedical sciences.

Leadership & Experience: Holding senior positions such as Associate Chief Physician and Director of Neurology, Dr. Wei has both clinical and research leadership experience, reinforcing his credentials as a top researcher.

🎓 Education

  • 🎓 2004.09-2009.06Xinxiang Medical University – Clinical Medicine (BD)
  • 🎓 2009.09-2012.06Harbin Medical University – Neurology (MD)
  • 🎓 2020.09-2023.06Harbin Medical University – Neurology (PhD)

💼 Experience

  • 2012.07-2015.05Resident Physician, Heilongjiang Provincial Hospital
  • 2015.05-2021.08Attending Physician, Heilongjiang Provincial Hospital
  • 2021.09-2024.03Associate Chief Physician, Heilongjiang Provincial Hospital
  • 2024.03-PresentAssociate Chief Physician, Huaian Hospital of Huaian City

🔬 Research Interests On Neuroscience

Dr. Wei’s research focuses on network pharmacology, bioinformatics analysis, and web data mining for scientific research. His work contributes to advancements in understanding neurological diseases, particularly in geriatric populations. He is proficient in analyzing large-scale medical data and has authored multiple research papers in high-impact journals.

🏆 Awards

  • 🌟 Principal investigator or key participant in multiple provincial-level research projects.
  • 🌟 Recognized for excellence in neurology research and contributions to geriatric neurological care.

📚 Publications

  • Title: Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
  • Authors: Quan P., Li X., Si Y., Yang F., Yao L., and others
  • Publication Year: 2024
  • Journal: Cell Communication and Signaling
  • Citations: 4

🔚 Conclusion

Dr. Chengqun Wei is a highly skilled neurologist with a strong academic background and clinical expertise in geriatric neurology. His contributions to research, particularly in bioinformatics and pharmacology, have positioned him as a key figure in neurological studies. His dedication to patient care and medical advancements continues to make a significant impact in the field of neurology.